Albumin regulates induction of peroxisome proliferator-activated receptor-γ (PPARγ) by 15-deoxy-Δ12-14-prostaglandin J2 in vitro and may be an important regulator of PPARγ function in vivo

Endocrinology

Volumn 142, Issue 2, 2001, Pages 551-556

  Person, E C ^a   Waite, L L ^a   Taylor, R N ^a   Scanlan, T S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY 12,14 PROSTAGLANDIN J2; ALBUMIN; ICOSANOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN DERIVATIVE; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROTECTION; CHORIOCARCINOMA; CONTROLLED STUDY; DISSOCIATION CONSTANT; GENETIC TRANSFECTION; GLUCOSE METABOLISM; HEAT TREATMENT; HUMAN; HUMAN CELL; LIPID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035107933     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.2.7965     Document Type: Article

References (42)

1. Peroxisome proliferator-activated receptors: Insights into multiple cellular functions
2. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
3. Placental peroxisome proliferator-activated receptor-γ is upregulated by pregnancy serum
4. An antidiabetic thiazolinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
5. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
6. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
7. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
8. 2 is a ligand for the adipocyte determination factor PPARγ
9. Inducible cycloxygenase may have anti-inflammatory properties
10. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ
11. Structure of serum albumin
12. Serum albumin
13. Fatty acid binding to human serum albumin: New insights from crystallographic studies
14. Which plasma factors bring about disturbance of endothelial function in pre-eclampsia?
15. Elevated nonesterified fatty acid concentrations in severe preeclampsia shift the isoelectric characteristics of plasma albumin
16. 12-13,14-dihydroprostaglandin D2, a metabolite of protaglandin D2 formed in human plasma
17. Albumin-eicosanoid interactions
18. 2
19. Albumin-lipid interactions: Prostaglandin stability as a probe for characterizing binding sites on vertebrate albumins
20. 2 with human serum albumin
21. 2 in human platelet-rich plasma
22. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone
23. [[ω-(Heterocyclylamino)alkocy]benzyl]-2,4-thazolidinediones as potent antihyperglycemic agents
24. The synthesis of BRL 49653: A novel and potent antihyperglycaemic agent
25. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridinyl)ethoxy]benzyl]-2,4thiazolidinedione (pioglitazone)
26. Species differences of serum albumins. II. Chemical and thermal stability
27. 2
28. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
29. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
30. 2, a ligand for peroxisome proliferator-activated receptor-γ, induces apoptosis in JEG3 choriocarcinoma cells
31. Peroxisome proliferator-activated receptor (PPAR) γ: Adipose-predominant expression and induction early in adipocyte differentiation
32. Peroxosome proliferator-activated receptor γ1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type 11 pneumonocytes
33. Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells
34. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
35. Terminal differentiation of human breast cancer through PPARγ
36. Differentiation and reversal of malignnt changes in colon cancer through PPARγ
37. Albumin synthesis and bone collagen formation in human immunodeficiency virus-positive subjects: Differential effects of growth hormone administration
38. Etiology and pathogenesis of preeclampsia: Current concepts
39. Coronary disease prediction using a new atherogenic index
40. Serum albumin level as a predictor of incident coronary heart disease: The Atherosclerosis Risk in Communities (AIRC) study
41. Nonenzymatic glycosylation of human serum albumin alters its conformation and function